In 2023, hospital discharges for soft tissue disorders in Canada were approximately 33.2 units per hundred thousand persons. Forecast data from 2024 to 2028 suggests a slight declining trend. The year-on-year variation is minor, with a decrease of 0.6% from 2024 to 2025, 0.6% from 2025 to 2026, 0.9% from 2026 to 2027, and 0.6% from 2027 to 2028. The five-year CAGR is expected to be around -0.7%, indicating a modest overall decline.
Future trends to watch for include:
- Advancements in minimally invasive techniques reducing the need for hospital discharges.
- Increases in outpatient and telemedicine services managing soft tissue disorders.
- Improvements in preventative care and rehabilitation reducing incidence and severity.
Our readers also like:
Forecast: Hospital Discharges for Soft Tissue Disorders Cases in Italy
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Deforming Dorsopathies and Spondylopathies in Italy
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Intervertebral Disc Disorders Cases in Germany
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Soft Tissue Disorders Cases in the UK
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Deforming Dorsopathies and Spondylopathies in Canada
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases in Germany
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Canada
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in the UK
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Soft Tissue Disorders Cases in Germany
- Days
- 2024 to 2028
- ReportLinker Research
Global Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases by Country
- Units (Hospital Discharges)
- 2023
- ReportLinker Research
Forecast: Hospital Discharges for Systemic Connective Tissue Disorders in the UK
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Systemic Connective Tissue Disorders in Canada
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Canada
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Soft Tissue Disorders Cases in Canada
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Soft Tissue Disorders Cases in France
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Systemic Connective Tissue Disorders in France
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Global Hospital Discharges for Systemic Connective Tissue Disorders by Country
- Units (Hospital Discharges)
- 2023
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Soft Tissue Disorders Cases in France
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Intervertebral Disc Disorders Cases in Canada
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Germany
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research